Crossmark

Updated cost-effectiveness analysis of first-line novel therapies in locally advanced or metastatic urothelial carcinoma across the UK, US, and China

Published Online: 2025-10-31

Authors

Lin, Jingwen

Fu, Wu

You, Caicong

Song, Xiaobin

Liu, Maobai

Cai, Hongfu
License Information

Text and Data Mining valid from 2025-10-31

Version of Record valid from 2025-10-31
More Information

Article History

Received: 23 May 2025

Accepted: 10 October 2025

First Online: 31 October 2025

Declarations

:

: The authors declare no competing interests.

: The authors declare that they have obtained written consent from all participants involved in the study to publish the data and findings.

: Not applicable.

Document is current